# 制药冷链包装市场 > 制药冷链包装市场研究报告：按包装类型（主动包装、被动包装、温控包装）、按材料（塑料、纸和纸板、金属、玻璃、复合材料）、按产品类型（绝缘运输箱、绝缘容器、凝胶包和冰包、相变材料、干冰）、按应用（疫苗、生物制品、药品、临床试验、实验室样本）以及按地区（北美、欧洲、南美、亚太、中东和非洲） - 预测到2035年。 - **Forecast Period:** 2025 - 2035 - **CAGR:** 8.32% - **2024:** $ 19.71 Billion - **2025:** $ 21.35 Billion - **2035:** $ 47.49 Billion - **Key Players:** Thermo Fisher Scientific (US), Sonoco Products Company (US), Pelican BioThermal (US), CSafe Global (US), DHL Supply Chain (DE), Envirotainer (SE), Cold Chain Technologies (US), Sofrigam (FR), Kuehne + Nagel (CH) **Report ID:** MRFR/PCM/39387-HCR · **Pages:** 128 · **Author:** Snehal Singh · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/pharmaceutical-cold-chain-packaging-market-28912 --- ## Market Summary ## **Global Pharmaceutical Cold Chain Packaging Market Overview** The Pharmaceutical Cold Chain Packaging Market Size was estimated at 19.71(USD Billion) in 2024. The Pharmaceutical Cold Chain Packaging Industry is expected to grow from 21.35 (USD Billion) in 2025 to 43.85 (USD Billion) by 2034. The Pharmaceutical Cold Chain Packaging Market CAGR (growth rate) is expected to be around 8.30% during the forecast period (2025 - 2034). ### **Key Pharmaceutical Cold Chain Packaging Market Trends Highlighted** Advancements in biotechnology and pharmaceuticals have fueled the demand for reliable pharmaceutical cold-chain packaging solutions. The growing prevalence of temperature-sensitive biologics, vaccines, and gene therapies necessitates secure and efficient transportation and storage. The adoption of smart packaging technologies, such as real-time temperature monitoring and data tracking, enhances visibility and control throughout the supply chain.Key market drivers include increasing globalization of pharmaceutical distribution, stringent regulatory requirements for the transportation of temperature-sensitive products, and the need for optimized supply chains. Opportunities lie in the development of innovative packaging materials and technologies that minimize environmental impact and streamline logistics processes.Recent trends include the integration of digitization and connectivity, enabling remote monitoring and predictive analytics. This enhances supply chain efficiency and reduces the risk of product spoilage. Additionally, the growing adoption of reusable and sustainable packaging solutions aligns with the industry's focus on environmental responsibility. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Pharmaceutical Cold Chain Packaging Market Drivers** ### Increasing Demand for Temperature-Sensitive Pharmaceutical Products The pharmaceutical industry is witnessing a surge in the development and production of temperature-sensitive drugs, vaccines, and biologics. These products require specialized packaging solutions to maintain their efficacy and safety during transportation and storage. Pharmaceutical cold chain packaging plays a critical role in ensuring the integrity and potency of these products throughout the supply chain. The growing demand for temperature-sensitive pharmaceuticals is a major driver for the growth of the Global Pharmaceutical Cold Chain Packaging Market Industry. ### Advancements in Packaging Technologies Technological advancements are revolutionizing the pharmaceutical cold chain packaging landscape. The introduction of innovative materials, such as insulated containers, phase change materials, and GPS tracking devices, is enhancing the efficiency and reliability of temperature-controlled packaging solutions. These advancements enable the precise monitoring and maintenance of optimal temperatures, reducing the risk of product spoilage and ensuring the quality of pharmaceutical products. ### Stringent Regulatory Compliance Regulatory bodies worldwide are implementing stringent guidelines and standards for the transportation and storage of pharmaceutical products. These regulations aim to ensure the safety and efficacy of pharmaceutical products throughout the supply chain. Compliance with these regulations requires the adoption of robust cold chain packaging solutions that meet specific temperature requirements and documentation standards. The increasing regulatory pressure is driving the demand for compliant packaging solutions in the Global Pharmaceutical Cold Chain Packaging Market Industry. ## **Pharmaceutical Cold Chain Packaging Market Segment Insights:** ### **Pharmaceutical Cold Chain Packaging Market Packaging Type Insights** The Global Pharmaceutical Cold Chain Packaging Market is segmented by Packaging Type into Active Packaging, Passive Packaging, and Temperature-controlled Packaging. Among these, Active Packaging held the largest market share in 2023, and it is expected to continue its dominance throughout the forecast period. The growth of this segment is attributed to the increasing demand for active packaging solutions, such as moisture absorbers and oxygen scavengers, to maintain the stability and efficacy of pharmaceutical products during transportation and storage.Passive Packaging is the second-largest segment in the Global Pharmaceutical Cold Chain Packaging Market. Passive packaging solutions, such as insulated containers and thermal blankets, are widely used for the transportation of temperature-sensitive pharmaceutical products. The growth of this segment is driven by the rising demand for cost-effective and reliable packaging solutions for short-distance transportation. Temperature-controlled Packaging is the fastest-growing segment in the Global Pharmaceutical Cold Chain Packaging Market. Temperature-controlled packaging solutions, such as refrigerated containers and cryogenic packaging, are essential for the transportation of highly sensitive pharmaceutical products, such as vaccines and biologics.The growth of this segment is fueled by the increasing demand for temperature-controlled packaging solutions to ensure the safe and effective delivery of these products. Overall, the Global Pharmaceutical Cold Chain Packaging Market is expected to grow significantly over the next ten years, driven by the increasing demand for pharmaceutical products and the need for effective and reliable packaging solutions to maintain their quality and efficacy throughout the supply chain. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Pharmaceutical Cold Chain Packaging Market Material Insights** The Global Pharmaceutical Cold Chain Packaging Market is segmented based on material into plastic, paper and paperboard, metal, glass, and composite materials. Plastic held the largest market share in 2023, accounting for over 50% of the global market revenue. The growth of the plastic segment can be attributed to its lightweight, durability, and cost-effectiveness. Paper and paperboard are also widely used in pharmaceutical cold-chain packaging due to their ability to provide insulation and protection. Metal containers are used for high-value and sensitive pharmaceutical products due to their ability to provide excellent barrier properties and protection from moisture and oxygen.Glass is another commonly used material, particularly for vials and ampoules, due to its transparency and inertness. Composite materials, which combine different materials to achieve specific properties, are gaining popularity due to their ability to provide both strength and insulation. ### **Pharmaceutical Cold Chain Packaging Market Product Type Insights**  The Global Pharmaceutical Cold Chain Packaging Market is segmented by product type into insulated shippers, insulated containers, gel packs and ice packs, phase change materials, and dry ice. Among these, insulated shippers held the largest market share in 2023 and are projected to continue their dominance throughout the forecast period. The growth of this segment can be attributed to the increasing demand for temperature-controlled packaging solutions for the transportation of pharmaceutical products that require strict temperature maintenance.Insulated shippers provide excellent insulation and protection against temperature fluctuations, ensuring the integrity and efficacy of the products during transit. The market for insulated containers is also expected to witness significant growth due to their ability to maintain consistent temperatures for extended periods, making them ideal for long-distance transportation. Gel packs and ice packs offer a cost-effective solution for short-term temperature control, while phase change materials provide a more sustainable option with their ability to absorb and release heat at specific temperatures.Dry ice is primarily used for ultra-low temperature applications, where temperatures below -78.5 degrees Celsius are required. The increasing adoption of personalized medicine and biologics is expected to drive the growth of the pharmaceutical cold chain packaging market in the coming years. ### **Pharmaceutical Cold Chain Packaging Market Application Insights** The Application segment of the Global Pharmaceutical Cold Chain Packaging Market is expected to witness significant growth over the forecast period. The key drivers of this growth include the increasing demand for temperature-sensitive pharmaceuticals, the growing prevalence of chronic diseases, and the rising adoption of personalized medicine. The vaccine segment is expected to account for the largest share of the market, owing to the increasing number of vaccination programs and the development of new vaccines. The Biologics segment is also expected to experience robust growth, driven by the rising demand for biologics for the treatment of various diseases.The Pharmaceuticals segment is expected to witness steady growth, supported by the increasing demand for pharmaceuticals for the treatment of chronic diseases. The Clinical Trials segment is also expected to contribute to the growth of the market as the number of clinical trials conducted globally continues to increase. The Laboratory Samples segment is expected to experience significant growth, driven by the increasing need for the transportation of laboratory samples for research and development purposes. Overall, the Application segment of the Global Pharmaceutical Cold Chain Packaging Market is expected to exhibit strong growth over the forecast period. ## **Pharmaceutical Cold Chain Packaging Market Key Players And Competitive Insights:** Major players in the Pharmaceutical Cold Chain Packaging Market industry are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and forming strategic partnerships. Leading Pharmaceutical Cold Chain Packaging Market players are focusing on developing innovative and sustainable packaging solutions to meet the evolving needs of the pharmaceutical industry. The Pharmaceutical Cold Chain Packaging Market development is driven by the increasing demand for temperature-controlled packaging for the transportation and storage of pharmaceutical products.A leading company in the Pharmaceutical Cold Chain Packaging Market specializes in providing comprehensive cold chain packaging solutions for the pharmaceutical industry. The company offers a wide range of packaging options, including insulated containers, refrigerated shipping containers, and temperature-controlled packaging systems. It has a global presence and serves a diverse customer base, including pharmaceutical manufacturers, distributors, and healthcare providers. The company is known for its commitment to quality and innovation, and it invests heavily in research and development to enhance its product offerings.A competitor company in the Pharmaceutical Cold Chain Packaging Market is recognized for its expertise in manufacturing and supplying high-performance cold chain packaging solutions. The company offers a range of products, including thermal insulation panels, phase change materials, and temperature monitoring devices. It has a strong focus on sustainability and offers eco-friendly packaging solutions to reduce environmental impact. The company has a global presence and caters to a wide range of customers in the pharmaceutical and healthcare industries. It is known for its customer-centric approach and provides tailored solutions to meet specific requirements. ### **Key Companies in the Pharmaceutical Cold Chain Packaging Market Include:** ## Pharmaceutical Cold Chain Packaging Market Industry Developments - **Q2 2024: Sonoco ThermoSafe Launches New Pegasus ULD Bulk Temperature Controlled Container for Pharmaceutical Air Freight** Sonoco ThermoSafe announced the launch of its Pegasus ULD bulk temperature controlled container, designed for pharmaceutical air freight, which is the first passive bulk temperature controlled container to receive FAA and EASA approvals for use on aircraft. - **Q2 2024: Pelican BioThermal Opens New Service Center in Incheon, South Korea** Pelican BioThermal, a global leader in temperature-controlled packaging, opened a new service center in Incheon, South Korea, to support the growing demand for cold chain solutions in the Asia-Pacific pharmaceutical market. - **Q2 2024: Softbox Systems Announces Partnership with SkyCell to Expand Sustainable Cold Chain Packaging Solutions** Softbox Systems entered into a partnership with SkyCell to jointly develop and offer sustainable, reusable cold chain packaging solutions for the pharmaceutical industry. - **Q3 2024: Cryoport Acquires Cell&Co BioServices to Expand European Cold Chain Logistics Capabilities** Cryoport, a leader in temperature-controlled supply chain solutions for the life sciences, acquired Cell&Co BioServices, a French biorepository and logistics provider, to strengthen its European cold chain logistics network. - **Q3 2024: Va-Q-tec to Open New Cold Chain Packaging Production Facility in India** Va-Q-tec announced the opening of a new production facility in India dedicated to manufacturing advanced cold chain packaging for pharmaceutical applications, aiming to meet rising demand in the region. - **Q3 2024: CSafe Appoints New CEO to Drive Global Expansion in Pharmaceutical Cold Chain Packaging** CSafe, a provider of temperature-controlled container solutions for pharmaceuticals, appointed a new CEO to lead the company’s global expansion and innovation strategy. - **Q4 2024: Envirotainer Launches Next-Generation RAP e2 Container for Biopharma Cold Chain** Envirotainer introduced its next-generation RAP e2 container, designed to provide enhanced temperature control and increased payload capacity for biopharmaceutical shipments. - **Q4 2024: Peli BioThermal Expands Global Network with New Drop Point in São Paulo, Brazil** Peli BioThermal expanded its global network by opening a new drop point in São Paulo, Brazil, to support pharmaceutical cold chain logistics in Latin America. - **Q1 2025: Sonoco ThermoSafe and United Cargo Announce Strategic Partnership for Pharmaceutical Cold Chain Logistics** Sonoco ThermoSafe and United Cargo formed a strategic partnership to enhance pharmaceutical cold chain logistics, offering expanded temperature-controlled shipping options for global pharma customers. - **Q1 2025: Cryopak Launches New Eco-Friendly Insulated Shipper for Pharmaceutical Cold Chain** Cryopak launched a new eco-friendly insulated shipper designed for the pharmaceutical cold chain, featuring recyclable materials and improved thermal performance. - **Q2 2025: Envirotainer Announces Major Contract Win with Leading Global Vaccine Manufacturer** Envirotainer secured a major contract to supply temperature-controlled containers for a leading global vaccine manufacturer, supporting the distribution of temperature-sensitive vaccines worldwide. - **Q2 2025: Pelican BioThermal Receives Regulatory Approval for New Credo Cube for Pharmaceutical Shipments** Pelican BioThermal received regulatory approval for its new Credo Cube, a temperature-controlled packaging solution designed for pharmaceutical shipments requiring strict temperature maintenance. ## **Pharmaceutical Cold Chain Packaging Market Segmentation Insights** ### **Pharmaceutical Cold Chain Packaging Market Packaging Type Outlook** ### **Pharmaceutical Cold Chain Packaging Market Material Outlook** ### **Pharmaceutical Cold Chain Packaging Market Product Type Outlook** ### **Pharmaceutical Cold Chain Packaging Market Application Outlook** ### **Pharmaceutical Cold Chain Packaging Market Regional Outlook** ## Market Drivers ### 疫苗分发的扩展 疫苗分发网络的持续扩展是制药冷链包装市场的重要驱动因素。随着越来越多的疫苗被开发和分发，特别是针对传染病的疫苗，对可靠冷链解决方案的需求变得前所未有的重要。预计到2025年，疫苗市场将超过1000亿美元，这突显了有效冷链管理的必要性。这包括温控包装，确保疫苗在从制造商到最终用户的整个过程中保持有效。因此，制药冷链包装市场可能会经历显著增长，因为它支持疫苗分发的物流，确保公共卫生倡议高效实现。 ### 包装中的技术创新 技术创新正在重塑制药冷链包装市场，提高温度敏感产品运输的效率和可靠性。先进的材料和智能包装解决方案，如温度指示器和数据记录仪，正变得越来越普遍。这些创新不仅改善了监测能力，还降低了产品变质的风险。智能包装市场预计将显著增长，估计到2025年复合年增长率超过10%。随着制药公司寻求优化其供应链，这些技术的整合到冷链包装解决方案中可能会推动制药冷链包装市场的增长。 ### 生物制剂需求上升 慢性疾病的日益普遍和对个性化医疗的日益关注正在推动生物制品的需求。这些产品在运输和存储过程中通常需要严格的温度控制，这就是制药冷链包装市场发挥关键作用的地方。根据最近的数据，生物制品市场预计到2025年将达到5000亿美元，这需要先进的冷链解决方案以保持产品的完整性。因此，制药公司正在大量投资冷链物流，以确保这些敏感产品安全有效地交付。这一趋势表明制药冷链包装市场将呈现出强劲的增长轨迹，因为它适应了医疗保健行业不断变化的需求。 ### 日益增加的监管要求 制药冷链包装市场受到健康监管机构日益严格的监管要求的显著影响。这些法规要求在药品的运输和存储过程中严格遵守温度控制标准。遵守这些法规对于维持产品的有效性和安全性至关重要，从而推动对专业冷链包装解决方案的需求。随着监管机构不断收紧指导方针，制药公司被迫投资于先进的冷链系统以确保合规。这一趋势预计将推动制药冷链包装市场的发展，因为公司寻求降低与不合规和产品召回相关的风险。 ### 制药行业电子商务的增长 制药行业电子商务的增长正成为制药冷链包装市场的关键驱动力。随着越来越多的消费者转向在线平台满足他们的药品需求，对高效可靠的冷链解决方案的需求正在上升。预计到2025年，制药行业的电子商务销售将达到1000亿美元，这需要强大的冷链物流以确保产品在运输过程中的完整性。这一向在线销售渠道的转变促使制药公司增强其冷链包装策略，从而推动制药冷链包装市场的增长。在最后一公里交付过程中，有效的温度控制尤为关键，因为它直接影响客户满意度和产品功效。 ## Future Outlook 制药冷链包装市场预计将在2024年至2035年间以8.32%的年均增长率增长，主要受对温度敏感药品需求增加和包装技术进步的推动。 **New opportunities:** - 与物联网集成的智能包装解决方案开发 到2035年，市场预计将实现强劲增长，主要受创新和战略投资的推动。 ## Segment Insights ### 按包装类型：被动包装（最大）与主动包装（增长最快） 在制药冷链包装市场中，不同包装类型的市场份额分布反映出对被动包装解决方案的显著偏好。被动包装已确立为最大的细分市场，主要是因为其在运输过程中无需主动组件即可有效维持温度稳定。另一方面，主动包装正在获得关注，成为增长最快的细分市场，原因在于对创新解决方案的需求日益增加，这些方案能够增强产品的保质期和有效性。 分析包装类型的增长趋势，显然对更复杂的冷链物流的推动正在激发对主动包装的兴趣。生物制品和温度敏感药物的增加促使制造商采用先进的包装方法。此外，强调在运输过程中制药产品完整性的监管标准正在推动两个细分市场的创新，突显出主动包装的强劲未来，同时被动包装仍将继续主导市场。 被动包装（主导）与主动包装（新兴） 被动包装仍然是制药冷链包装市场的主导力量，其特点是简单可靠。它通常包括使用热量保持所需温度的绝缘容器，在整个运输过程中保持规定的温度。这种类型的包装因其稳定性和标准化而受到特别青睐，提供有效且具有成本效益的解决方案。另一方面，主动包装代表了一个新兴领域，利用技术监测和调整内部环境，确保敏感产品的最佳条件。其增长趋势受到制药行业对增强安全性和有效性的日益要求的推动，在产品完整性至关重要的市场中提供了竞争优势。随着主动解决方案的逐步普及，它们与被动方法相辅相成，展示了一个满足多样化制药需求的多面市场。 ### 按材料：塑料（最大）与玻璃（增长最快） 在制药冷链包装市场中，‘材料’细分市场展示了多样化的分布，其中塑料占据主导地位，这归因于其轻便、灵活和具有成本效益的特性。其他材料如纸和纸板、金属、玻璃和复合材料各自占据独特的细分市场，满足特定的包装需求，但并未掩盖塑料在市场份额上的主导地位。 该细分市场的增长趋势受到对温度敏感的药品需求增加的推动，这些药品需要安全可靠的包装解决方案。玻璃作为增长最快的选项，因其可持续性吸引力和对有害外部元素的保护特性而获得关注。行业不断变化的环境法规进一步促进了玻璃包装的采用，吸引了环保意识强的消费者和制造商。 塑料（主导）与玻璃（新兴） 塑料包装在制药冷链包装市场中占据主导地位，以其维持温度控制和易于处理而受到好评。它对湿气和污染物具有优异的屏障性能，这对于保护敏感药品至关重要。鉴于其适应性，它适用于各种形状和尺寸，简化了制造商的生产过程。相比之下，玻璃因其卓越的保护特性和高端吸引力而在市场上崭露头角。尽管比其对手更重且更脆弱，玻璃因其惰性特性和可回收性而越来越受到高端制药产品的青睐。其增长轨迹反映了向可持续包装解决方案的转变，符合行业趋势，优先考虑环境影响。 ### 按产品类型：绝缘运输箱（最大）与凝胶包和冰袋（增长最快） 制药冷链包装市场主要由绝缘运输箱驱动，绝缘运输箱在产品类型细分中占据最大份额。这些运输箱旨在在储存和运输过程中保持制药产品所需的温度条件，以确保最大效力。紧随其后的是凝胶包和冰包，由于其在短期运输中的实用性和有效性而迅速增长。对温度敏感产品的需求不断增加，强调了可靠绝缘包装的重要性，促进了绝缘运输箱在市场上的持续增长。 绝缘运输箱（主导）与干冰（新兴） 绝缘运输箱在制药冷链包装市场中发挥着关键作用，为敏感物质提供无与伦比的温度控制。它们的设计适应各种尺寸和配置，使其在多样化的制药需求中高度灵活和适应性强。相比之下，干冰虽然被标记为一种新兴解决方案，但由于其有效维持极低温度的能力，正在获得越来越多的关注。随着市场的发展，针对特定制药应用的干冰等定向解决方案的需求正在增加，这使其在更广泛的包装领域中开辟了一个重要的细分市场。 ### 按应用：疫苗（最大）与生物制剂（增长最快） 在制药冷链包装市场中，各种应用之间的市场份额分布反映了维持温度敏感产品的重要性。疫苗在市场中占据主导地位，由于免疫接种计划的增加和全球大流行，疫苗占据了相当大的份额。紧随其后，生物制剂正在获得关注，得益于生物技术的进步和对生物治疗的日益需求。临床试验和实验室样本领域进一步补充了这一趋势，尽管规模较小，但对可靠的冷链解决方案的整体需求贡献显著。 疫苗（主导）与生物制剂（新兴） 疫苗被认为是制药冷链包装市场的主导力量，主要是由于对严格温度控制的基本要求，以确保其有效性和安全性。全球范围内日益扩大的疫苗接种计划，特别是针对新兴健康威胁的响应，突显了需要先进的包装解决方案，以维持从生产到施用的冷链。相反，生物制剂代表了一个新兴领域，其特点是快速增长，受到创新治疗和个性化医学的推动。随着治疗领域的演变，处理生物制剂独特储存条件的专业冷链物流的需求变得至关重要，这突显了在维持理想温度曲线以确保产品完整性方面的挑战。 ## Regional Market Share Analysis ### 北美：冷链市场领导者 北美是制药冷链包装最大的市场，约占全球市场份额的45%。该地区的增长受到对温度敏感药品需求增加、严格的监管要求以及包装技术进步的推动。美国是主要贡献者，其次是加拿大，加拿大正在迅速扩展其冷链物流能力，以满足日益增长的医疗需求。 北美的竞争格局强劲，主要参与者包括Thermo Fisher Scientific、Pelican BioThermal和CSafe Global。这些公司在创新解决方案上投入巨资，以提高效率并遵守法规。成熟的物流网络和对研发的强烈关注进一步巩固了该地区的市场地位。 ### 欧洲：监管驱动的市场增长 欧洲是制药冷链包装的第二大市场，约占全球市场份额的30%。该地区的增长受到欧洲药品管理局（EMA）严格法规的推动，以及对生物制剂和生物仿制药需求的增加。德国和法国等国在市场中处于领先地位，强调包装解决方案的质量保证和可持续性。 欧洲的竞争格局由一系列成熟企业和创新初创公司组成。DHL供应链和Envirotainer等公司处于前沿，专注于先进的温控物流。该地区对监管合规和环境可持续性的承诺推动了新包装技术的发展，确保温度敏感药品的安全运输。 ### 亚太地区：新兴市场潜力 亚太地区的制药冷链包装市场正在快速增长，约占全球市场份额的20%。该地区的扩展受到医疗支出增加、人口增长以及对疫苗和生物制剂需求上升的推动。中国和印度等国在这一增长中处于领先地位，政府倡议支持改善医疗基础设施和物流能力。 亚太地区的竞争格局正在演变，本地和国际参与者争夺市场份额。Cold Chain Technologies和Kuehne + Nagel等公司正在扩大其运营，以满足日益增长的需求。该地区对提高供应链效率和遵守法规的关注预计将在未来几年进一步增强其市场地位。 ### 中东和非洲：未开发的市场机会 中东和非洲地区正在成为制药冷链包装市场的重要参与者，约占全球市场份额的5%。增长受到对医疗基础设施投资增加和对温度敏感产品需求上升的推动。南非和阿联酋等国在前沿，专注于提升其冷链物流能力，以满足国际标准。 该地区的竞争格局仍在发展中，本地和国际公司混合进入市场。主要参与者专注于建立合作伙伴关系和提高供应链效率。该地区的增长潜力巨大，受到日益增长的医疗需求和旨在确保药品安全运输的监管改善的推动。 ## Competitive Benchmarking 制药冷链包装市场的特点是动态的竞争格局，受到对温度敏感的药品和生物制品需求不断增长的推动。主要参与者积极采取强调创新、区域扩展和合作伙伴关系的策略，以增强其市场定位。像Thermo Fisher Scientific（美国）、Pelican BioThermal（美国）和CSafe Global（美国）等公司处于前沿，利用其技术能力和广泛的分销网络来满足制药行业不断变化的需求。他们共同关注提高供应链效率和可靠性，正在重塑竞争环境，营造出运营卓越至关重要的氛围。 在商业策略方面，公司越来越多地本地化制造并优化其供应链，以迅速响应市场需求。市场结构似乎适度分散，多个参与者争夺市场份额，同时通过战略合作伙伴关系进行合作。这些主要参与者的集体影响不仅增强了他们的竞争优势，还推动了整个行业的创新，因为公司寻求通过先进的包装解决方案和服务来实现差异化。 2025年8月，Thermo Fisher Scientific（美国）宣布推出一系列专为生物制药行业设计的温控包装解决方案。这一战略举措具有重要意义，因为它与个性化医疗日益增长的趋势相一致，在这种趋势中，精确的温度控制对维持产品完整性至关重要。通过扩展其产品系列，Thermo Fisher旨在巩固其在冷链包装市场的领导地位，满足生物制药制造商的独特需求。 2025年9月，Pelican BioThermal（美国）与一家领先的物流提供商揭晓了合作伙伴关系，以增强其全球分销能力。这一合作有望提高温度敏感货物的运输效率，从而缩短运输时间并确保遵守严格的监管要求。这一合作伙伴关系的战略重要性在于其潜力，可以扩大Pelican的市场覆盖范围，同时加强其提供可靠冷链解决方案的承诺。 2025年7月，CSafe Global（美国）完成了对一家欧洲冷链包装公司的收购，预计将增强其在欧洲市场的存在。这一收购不仅增强了CSafe的产品组合，还允许实现更大的运营协同和成本效率。这一举措的战略重要性在于，欧洲对冷链解决方案的需求不断增长，推动了该地区强大的制药行业。 截至2025年10月，制药冷链包装市场的竞争趋势越来越多地受到数字化、可持续性和人工智能整合的定义。公司正在形成战略联盟，以利用技术进步并增强其服务产品。竞争从基于价格的竞争转向关注创新、技术和供应链可靠性，这一转变显而易见，表明未来的竞争差异化将取决于提供优越、可持续的解决方案的能力，以满足制药行业复杂的需求。 ## Recent News & Developments - **2024年第二季度：Sonoco ThermoSafe推出新款Pegasus ULD大宗温控集装箱，用于制药航空货运** Sonoco ThermoSafe宣布推出其Pegasus ULD大宗温控集装箱，专为制药航空货运设计，这是首个获得FAA和EASA批准可在飞机上使用的被动大宗温控集装箱。 - **2024年第二季度：Pelican BioThermal在韩国仁川开设新服务中心** Pelican BioThermal，全球温控包装的领导者，在韩国仁川开设了新的服务中心，以支持亚太制药市场对冷链解决方案日益增长的需求。 - **2024年第二季度：Softbox Systems宣布与SkyCell建立合作伙伴关系，以扩展可持续冷链包装解决方案** Softbox Systems与SkyCell达成合作伙伴关系，共同开发和提供可持续的可重复使用的冷链包装解决方案，服务于制药行业。 - **2024年第三季度：Cryoport收购Cell&Co BioServices，以扩展欧洲冷链物流能力** Cryoport，生命科学领域温控供应链解决方案的领导者，收购了法国生物储存和物流提供商Cell&Co BioServices，以增强其欧洲冷链物流网络。 - **2024年第三季度：Va-Q-tec将在印度开设新的冷链包装生产设施** Va-Q-tec宣布在印度开设新的生产设施，专注于制造先进的制药应用冷链包装，以满足该地区日益增长的需求。 - **2024年第三季度：CSafe任命新首席执行官，以推动制药冷链包装市场的全球扩张** CSafe，温控集装箱解决方案的提供商，任命新首席执行官，以领导公司的全球扩张和创新战略。 - **2024年第四季度：Envirotainer推出下一代RAP e2集装箱，用于生物制药冷链** Envirotainer推出其下一代RAP e2集装箱，旨在为生物制药运输提供增强的温控和更高的载货能力。 - **2024年第四季度：Peli BioThermal在巴西圣保罗扩展全球网络，开设新投递点** Peli BioThermal通过在巴西圣保罗开设新投递点，扩展其全球网络，以支持拉丁美洲的制药冷链物流。 - **2025年第一季度：Sonoco ThermoSafe与United Cargo宣布战略合作伙伴关系，以增强制药冷链物流** Sonoco ThermoSafe与United Cargo建立战略合作伙伴关系，以增强制药冷链物流，为全球制药客户提供扩展的温控运输选项。 - **2025年第一季度：Cryopak推出新款环保绝缘运输箱，用于制药冷链** Cryopak推出新款环保绝缘运输箱，专为制药冷链设计，采用可回收材料并提高热性能。 - **2025年第二季度：Envirotainer宣布与领先全球疫苗制造商达成重大合同** Envirotainer获得一项重大合同，为一家领先的全球疫苗制造商提供温控集装箱，支持温度敏感疫苗的全球分发。 - **2025年第二季度：Pelican BioThermal获得新款Credo Cube的监管批准，用于制药运输** Pelican BioThermal获得新款Credo Cube的监管批准，这是一种专为需要严格温度维护的制药运输设计的温控包装解决方案。 ## Report Scope | 2024年市场规模 | 197.1（十亿美元） | | --- | --- | | 2025年市场规模 | 213.5（十亿美元） | | 2035年市场规模 | 474.9（十亿美元） | | 复合年增长率（CAGR） | 8.32%（2024 - 2035） | | 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 | | 基准年 | 2024 | | 市场预测期 | 2025 - 2035 | | 历史数据 | 2019 - 2024 | | 市场预测单位 | 十亿美元 | | 主要公司简介 | 市场分析进行中 | | 覆盖的细分市场 | 市场细分分析进行中 | | 主要市场机会 | 先进温度监测技术的整合提高了制药冷链包装市场的可靠性。 | | 主要市场动态 | 对温度敏感药品需求的增加推动了冷链包装解决方案和法规合规性的创新。 | | 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 | ## Frequently Asked Questions **Q: 制药冷链包装市场的当前估值是多少？** A: 2024年市场估值为197.1亿美元。 **Q: 到2035年，制药冷链包装市场的预计市场规模是多少？** A: 预计到2035年，市场将达到474.9亿美元。 **Q: 在2025年至2035年的预测期内，制药冷链包装市场的预期CAGR是多少？** A: 预计在预测期内，CAGR为8.32%。 **Q: 在制药冷链包装市场中，哪些公司被视为关键参与者？** A: 主要参与者包括赛默飞世尔科技公司、索诺科产品公司和佩利肯生物热控公司等。 **Q: 制药冷链包装市场的主要细分领域是什么？** A: 主要细分包括包装类型、材料、产品类型和应用。 **Q: 2025年，被动包装的估值与主动包装相比如何？** A: 被动包装预计将达到250亿美元，而主动包装预计将达到85亿美元。 **Q: 到2035年，塑料作为制药冷链包装市场材料的预计估值是多少？** A: 预计到2035年，塑料的市场将达到180亿美元。 **Q: 到2035年，预计在制药冷链包装市场中，哪种产品类型的估值最高？** A: 绝缘容器预计到2035年将达到100亿美元。 **Q: 在制药冷链包装市场中，预计哪个应用领域将增长最多？** A: 预计到2035年，疫苗的市场规模将增长至120亿美元。 **Q: 复合材料的增长与市场上其他材料相比如何？** A: 复合材料预计将达到144.9亿美元，显示出强劲的增长潜力。 --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/pharmaceutical-cold-chain-packaging-market-28912*